Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

News

  1. Home>
  2. News>
  3. Page 16

Understanding Bioequivalence: Why Indian Generic Medicines Work as Well as Branded Drugs

  • Post published:June 22, 2026
  • Post category:Knowledge

One of the most common questions international buyers ask about Indian generic medicines is: "Are they really as effective as the original branded drug?" The answer lies in a rigorous…

Continue Reading Understanding Bioequivalence: Why Indian Generic Medicines Work as Well as Branded Drugs

Indian Pharma’s Strategic Pivot from Generics to Specialty Drugs and Biosimilars

  • Post published:June 21, 2026
  • Post category:News

Indian pharmaceutical companies, long celebrated as the “pharmacy of the world” for their affordable generic medicines, are now charting a strategic course toward specialty drugs, biosimilars, and innovative therapies. This…

Continue Reading Indian Pharma’s Strategic Pivot from Generics to Specialty Drugs and Biosimilars

How to Verify the Quality of Indian Generic Medicine Manufacturers: A Buyer’s Guide

  • Post published:June 20, 2026
  • Post category:Knowledge

India is the world's largest supplier of generic medicines, exporting over US$25 billion worth of pharmaceuticals annually to more than 200 countries. But with volume comes risk — not all…

Continue Reading How to Verify the Quality of Indian Generic Medicine Manufacturers: A Buyer’s Guide

Indian Pharma’s $19.1B US Push Amid Generics Tariff Exemption

  • Post published:June 20, 2026
  • Post category:News

🇺🇸 US Imposes 100% Tariff on Patented Drug Imports from India In a major trade policy shift, the United States imposed a 100% tariff on patented pharmaceutical products imported from…

Continue Reading Indian Pharma’s $19.1B US Push Amid Generics Tariff Exemption
  • Go to the previous page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 79
  • Go to the next page

Recent Posts

  • CDSCO Mandates Pharma Companies to Maintain Adverse Event Reporting Systems
    September 1, 2026/
    0 Comments
  • India Pushes for Pharma Market Access in Argentina and Brazil
    August 31, 2026/
    0 Comments
  • India’s Pharma Ambitions Meet Regulatory Capacity: What Buyers Should Know
    August 30, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • CDSCO Mandates Pharma Companies to Maintain Adverse Event Reporting Systems
  • India Pushes for Pharma Market Access in Argentina and Brazil
  • India’s Pharma Ambitions Meet Regulatory Capacity: What Buyers Should Know
  • CBN and PHARMEXCIL Sign MoU on Controlled Substances Exports
  • Understanding India’s Drug Safety Framework: A 2026 Buyer’s Guide

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve